How to use the speech recognition tool?
Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation.
Status of the trial: Completed
Orphan Drug Recognition: NA
Funder Type: industry
Principal location of the trial
HCP: Principal investigators
HCP: Other investigators